Translational Research on Rare Diseases
GIRBER: Recognised Research Group in Biomedicine of Rare Diseases at the University of Salamanca

About GIRBER
In our research group, we focus on the genetic diagnosis of paediatric patients with rare diseases. Our objective is to investigate the molecular foundations of these rare diseases to aid diagnosis and enhance understanding of their molecular mechanisms. Our findings contribute to determining whether the mutations identified in patients’ DNA are the cause of the disease. Additionally, we aim to support genetic counselling and the development of personalised therapies. Our team comprises physicians, biologists, biotechnologists, and pharmacists.
Research Lines

Phenotypes – Functional Genetics of Rare Diseases

Advanced Molecular Diagnosis of Ultra-Rare Diseases

Cancer and Rare Diseases

RASopathies
Recent Publications
2025
2024
Biomarker Landscape in RASopathies
International Journal of Molecular Sciences, Vol. 25, Núm. 16
Clinical and Genetic Characterization of a Cohort of Small-for-Gestational-Age Patients: Cost-Effectiveness of Whole-Exome Sequencing and Effectiveness of Treatment with GH
Journal of Clinical Medicine, Vol. 13, Núm. 14
Non-Mammalian Models for Understanding Neurological Defects in RASopathies
Biomedicines, Vol. 12, Núm. 4
PTEN hamartoma tumor syndrome: Clinical and genetic characterization in pediatric patients
Child’s Nervous System, Vol. 40, Núm. 6, pp. 1689-1697
2023
Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells
Cardiovascular Diabetology, Vol. 22, Núm. 1
Exploring the Role of Osteoglycin in Type 2 Diabetes: Implications for Insulin Resistance and Vascular Pathophysiology
American Journal of Physiology-Endocrinology and Metabolism, Vol. 325, Núm. 4
The therapeutic potential of neurofibromin signaling pathways and binding partners
Communications Biology, Vol. 6, Núm. 1
2022
Identification of Germinal Neurofibromin Hotspots
Biomedicines, Vol. 10, Núm. 8
2021
Dictyostelium discoideum as a non-mammalian biomedical model
Microbial Biotechnology, Vol. 14, Núm. 1, pp. 111-125
Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins
Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1
NAMPT-derived NAD+fuels PARP1 to promote skin inflammation through parthanatos cell death
PLoS Biology, Vol. 19, Núm. 11
Supports research
The donation funds are allocated exclusively to activities directly related to scientific projects.